DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 16451 - 16475 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID Gene Name UniProt ID ▼
C0028754 Obesity ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0549473 Thyroid carcinoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0003873 Rheumatoid Arthritis ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0006142 Malignant neoplasm of breast ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C1306459 Primary malignant neoplasm ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0279607 Adult Hepatocellular Carcinoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C2239176 Liver carcinoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0699885 Carcinoma of bladder ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0205824 Liposarcoma, Dedifferentiated ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0242379 Malignant neoplasm of lung ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0016037 Fibrodysplasia Ossificans Progressiva ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0019158 Hepatitis ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C4520983 Congenital atresia of extrahepatic bile duct ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0036421 Systemic Scleroderma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0752125 Spinocerebellar Ataxia Type 7 ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0279606 Childhood Hepatocellular Carcinoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C1621958 Glioblastoma Multiforme ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0027819 Neuroblastoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0238463 Papillary thyroid carcinoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0600139 Prostate carcinoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0151468 Thyroid Gland Follicular Adenoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0007134 Renal Cell Carcinoma ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0027651 Neoplasms ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C0005779 Blood Coagulation Disorders ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822
C1458155 Mammary Neoplasms ENPP2 5168 ectonucleotide pyrophosphatase/phosphodiesterase 2 Q13822

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024